|
US3853893A
(en)
*
|
1973-04-02 |
1974-12-10 |
Squibb & Sons Inc |
Anthelmintic 5-(pyridyl)-3-(isothiocyanophenyl) oxadiazoles
|
|
HU177086B
(en)
*
|
1975-06-09 |
1981-07-28 |
Eszakmagyar Vegyimuevek |
Herbicide and fungicide preparation containing substituted 1,2,4-oxadiazolidin-3-one derivatives
|
|
JPS58150576A
(ja)
*
|
1982-03-03 |
1983-09-07 |
Sumitomo Chem Co Ltd |
新規な１，２，４−オキサジアゾ−ル誘導体
|
|
DE3247118A1
(de)
*
|
1982-12-20 |
1984-06-20 |
Cassella Ag, 6000 Frankfurt |
Neue substituierte 1,4-dihydropyridine, verfahren zu ihrer herstellung und ihre verwendung als arzneimittel
|
|
ATE307129T1
(de)
*
|
1999-08-19 |
2005-11-15 |
Nps Pharma Inc |
Heteropolycyclische verbindungen und ihre verwendung als antagonisten von metabotropen glutamatrezeptoren
|
|
EP1582519A3
(en)
*
|
1999-08-19 |
2005-12-21 |
Nps Pharmaceuticals, Inc. |
Heteropolycyclic compounds and their use as metabotropic glutamate receptor antagonists
|
|
US6660753B2
(en)
*
|
1999-08-19 |
2003-12-09 |
Nps Pharmaceuticals, Inc. |
Heteropolycyclic compounds and their use as metabotropic glutamate receptor antagonists
|
|
PL369598A1
(en)
*
|
2001-02-21 |
2005-05-02 |
Nps Pharmaceuticals, Inc. |
Heteropolycyclic compounds and their use as metabotropic glutamate receptor antagonists
|
|
AU2003264018A1
(en)
|
2002-08-09 |
2004-02-25 |
Astrazeneca Ab |
Compounds having an activity at metabotropic glutamate receptors
|
|
AU2004229392A1
(en)
*
|
2003-04-09 |
2004-10-28 |
Exelixis, Inc. |
Tie-2 modulators and methods of use
|
|
CA2524867A1
(en)
*
|
2003-05-15 |
2004-12-02 |
Merck & Co., Inc. |
3-(2-amino-1-azacyclyl)-5-aryl-1,2,4-oxadiazoles as s1p receptor agonists
|
|
US20060189661A1
(en)
*
|
2003-11-03 |
2006-08-24 |
Wagenen Bradford V |
Heteropolycyclic compounds and their use as metabotropic glutamate receptor antagonists
|
|
WO2005060961A2
(en)
*
|
2003-12-18 |
2005-07-07 |
Astrazeneca Ab |
Treatment of transient lower esophageal sphincter relaxations (tlesrs) and gastro-esophageal reflux disease (gerd)
|
|
US8207147B2
(en)
*
|
2003-12-24 |
2012-06-26 |
Prosidion Limited |
Heterocyclic derivatives as GPCR receptor agonists
|
|
WO2005077368A2
(en)
*
|
2004-02-03 |
2005-08-25 |
Astrazeneca Ab |
Treatment of gastro-esophageal reflux disease (gerd)
|
|
CA2606087A1
(en)
*
|
2005-04-26 |
2006-11-02 |
Neurosearch A/S |
Novel oxadiazole derivatives and their medical use
|
|
IL169855A
(en)
*
|
2005-07-25 |
2014-05-28 |
Elta Systems Ltd |
A system and method for locating a receiver location
|
|
WO2007013830A1
(en)
|
2005-07-26 |
2007-02-01 |
Portela & Ca. S.A. |
Nitrocatechol derivatives as comt inhibitors
|
|
EP1845097A1
(en)
*
|
2006-04-10 |
2007-10-17 |
Portela & Ca., S.A. |
Oxadiazole derivatives as COMT inhibitors
|
|
JP5253401B2
(ja)
*
|
2006-09-07 |
2013-07-31 |
アクテリオン ファーマシューティカルズ リミテッド |
免疫調節薬としてのピリジン−４−イル誘導体
|
|
CL2007002594A1
(es)
*
|
2006-09-08 |
2008-06-06 |
Actelion Pharmaceuticals Ltd |
Compuestos derivados de piridin-3-il, agentes inmunomoduladores; composicion farmaceutica que comprende a dicho compuesto; y uso del compuesto en el tratamiento de enfermedades asociadas con un sistema inmunologico activado. .
|
|
DK2481410T3
(en)
*
|
2007-01-31 |
2016-10-24 |
Bial - Portela & Ca S A |
Nitrocatecholderivater as COMT inhibitors administered in a specific dosage regimen
|
|
DK2125797T3
(da)
*
|
2007-03-16 |
2014-02-10 |
Actelion Pharmaceuticals Ltd |
Aminopyridinderivater som s1p1/edg1-receptoragonister
|
|
EP2195311B1
(en)
*
|
2007-08-17 |
2011-03-23 |
Actelion Pharmaceuticals Ltd. |
Pyridine derivatives as s1p1/edg1 receptor modulators
|
|
EP2259777A2
(en)
*
|
2008-02-28 |
2010-12-15 |
BIAL - Portela & Ca., S.A. |
Pharmaceutical composition for poorly soluble drugs
|
|
CN101965345B
(zh)
*
|
2008-03-06 |
2014-05-28 |
埃科特莱茵药品有限公司 |
吡啶化合物
|
|
JP5435745B2
(ja)
*
|
2008-03-07 |
2014-03-05 |
アクテリオン ファーマシューティカルズ リミテッド |
免疫調節剤としてのピリジン−２−イル誘導体
|
|
BRPI0908731A2
(pt)
|
2008-03-17 |
2017-05-16 |
Bial - Portela & C A S A |
formas cristalinas de 5-[3-(2,5-dicloro-4,6-dimetil-1-óxi-piridina-3-il)[1,2,4]oxadiazol-5-il]-3-nitrobenzeno-1,2-diol
|
|
PT2291080E
(pt)
*
|
2008-05-14 |
2015-10-30 |
Scripps Research Inst |
Novos modelamodeladores dos recetores da esfingosina fosfato
|
|
HUE025314T2
(en)
|
2009-02-10 |
2016-02-29 |
Monsanto Technology Llc |
Preparations and procedures for controlling nematodes
|
|
CN102448444B
(zh)
|
2009-04-01 |
2016-05-25 |
巴尔-波特拉及康邦亚股份有限公司 |
包括硝基儿茶酚衍生物的药物制剂及其制备方法
|
|
PT2413913T
(pt)
*
|
2009-04-01 |
2022-06-09 |
Bial Portela & Ca Sa |
Formulações farmacêuticas que compreendem derivados de nitrocatecol e métodos para os preparar
|
|
TWI410421B
(zh)
|
2009-07-16 |
2013-10-01 |
Actelion Pharmaceuticals Ltd |
吡啶－４－基衍生物
|
|
CA2818470C
(en)
|
2011-01-19 |
2019-03-05 |
Actelion Pharmaceuticals Ltd |
2-methoxy-pyridin-4-yl derivatives
|
|
US20140045900A1
(en)
|
2011-02-11 |
2014-02-13 |
Bial-Portela & Ca, S.A. |
Administration regime for nitrocatechols
|
|
US9126988B2
(en)
|
2011-12-13 |
2015-09-08 |
Bial—Portela & Ca, S.A. |
Intermediate for preparing a catechol-O-methyltransferase inhibitor
|
|
CN105143214B
(zh)
*
|
2013-02-15 |
2018-04-03 |
孟山都技术公司 |
用于控制线虫害虫的3,5‑二取代的‑4,5‑二氢‑1,2,4‑噁二唑
|
|
WO2016083863A1
(en)
|
2014-11-28 |
2016-06-02 |
Bial - Portela & Ca, S.A. |
Medicaments for slowing parkinson's disease
|
|
ES2770348T3
(es)
|
2015-05-20 |
2020-07-01 |
Idorsia Pharmaceuticals Ltd |
Forma cristalina del compuesto (s)-3-{4-[5-(2-ciclopentil-6-metoxi-piridin-4-il)-[1,2,4]oxadiazol-3-il]-2-etil-6-metil-fenoxi}-propano-1,2-diol
|